January 6, 2021 -- Life sciences company Vizgen has established an accelerator lab in the U.S. to advance pharmaceutical research and development.
The pharma accelerator lab was launched to meet the high demand from pharmaceutical companies who continue to turn to single-cell and spatial transcriptomics technology to speed up drug development pipelines.
Additionally, Vizgen began an early release program so scientific investigators could gain access to its multiplexed error-robust fluorescence in situ hybridization (MERFISH) platform ahead of its commercial launch.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
